| 詳細情報 |  |
|---|---|
| 関連リンク |  |
| 探す |  |
論文 (64件)
- Masahito Nakano, Machiko Kawaguchi, Dan Nakano, Tomoya Sano, Keisuke Amano, Toru Nakamura, Hirokazu Takahashi, Kunio Tarasawa, Kenji Fujimori, Takumi Kawaguchi. Regional Difference of Liver Cancer in Japan: A Real-world Evidence Using the National Database of Health Insurance Claims. Internal medicine (Tokyo, Japan). 2025
- Nakamura T, Nakano M, Tsutsumi T, Amano K, Kawaguchi T. Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis". Clinical and Molecular Hepatology. 2024. 30. 4. 705-708
- Atsutaka Masuda, Toru Nakamura, Hideki Iwamoto, Hiroyuki Suzuki, Takahiko Sakaue, Toshimitsu Tanaka, Yasuko Imamura, Nobuyuki Mori, Hironori Koga, Takumi Kawaguchi. Ex-vivo expanded CD34+ cell transplantation alleviates fibrotic liver injury via innate immune modulation in metabolic dysfunction-associated steatohepatitis mice. Cytotherapy. 2024. 26. 8. 899-909
- Jia Hong Koh, Douglas Chee, Cheng Han Ng, Karn Wijarnpreecha, Mark Muthiah, Darren Jun Hao Tan, Wen Hui Lim, Rebecca Wenling Zeng, Benjamin Koh, Eunice Tan Xiang Xuan, et al. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH. Transplantation direct. 2024. 10. 7. e1642
- Toshimitsu Tanaka, Hironori Koga, Hiroyuki Suzuki, Hideki Iwamoto, Takahiko Sakaue, Atsutaka Masuda, Toru Nakamura, Jun Akiba, Hirohisa Yano, Takuji Torimura, et al. Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells. Hepatology international. 2024. 18. 3. 984-997
- Nakamura T, Masuda A, Kako M, Enomoto H, Kaibori M, Fujita Y, Tanizawa K, Ioji T, Fujimori Y, Fukami K, Hazama T, Iwamoto H, Kako Y, Kobayashi K, Koga H, Nagafuji K, Ohtake T, Suzuki H, Takashima T, Tsukiyama T, Uojima H, Yamahara K, Yamakado K, Yamamoto H, Yoh K, Yoshihara S, Kawamoto A, Nishiguchi S, Kobayashi S, Torimura T, Kawaguchi T. Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial. Regenerative Therapy. 2024. 27. 455-463
- Hiroyuki Suzuki, Hideki Iwamoto, Toshimitsu Tanaka, Takahiko Sakaue, Yasuko Imamura, Atsutaka Masuda, Toru Nakamura, Hironori Koga, Yujin Hoshida, Takumi Kawaguchi. Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma. Hepatology international. 2024. 18. 2. 610-622
- Hideki Iwamoto, Hiroyuki Suzuki, Atsutaka Masuda, Takahiko Sakaue, Toru Nakamura, Toshimitsu Tanaka, Miwa Sakai, Yasuko Imamura, Hirohisa Yano, Takuji Torimura, et al. A tumor endothelial cell-specific microRNA replacement therapy for hepatocellular carcinoma. iScience. 2024. 27. 2. 108797-108797
- Takahiko Sakaue, Hironori Koga, Hideki Iwamoto, Toru Nakamura, Atsutaka Masuda, Toshimitsu Tanaka, Hiroyuki Suzuki, Hideya Suga, Shingo Hirai, Toru Hisaka, et al. Pancreatic Juice-Derived microRNA-4516 and microRNA-4674 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma. Gastro hep advances. 2024. 3. 6. 761-772
- Hiroyuki Suzuki, Hideki Iwamoto, Takahiro Seki, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Yasuko Imamura, Takashi Niizeki, Masahito Nakano, et al. Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors. Cancer communications (London, England). 2023. 43. 4. 415-434
- Toshimitsu Tanaka, Hiroyuki Suzuki, Keisuke Miwa, Tomoyuki Ushijima, Sachiko Nagasu, Masaru Fukahori, Kaito Ishii, Toru Nakamura, Hideki Iwamoto, Atsutaka Masuda, et al. Hyperlipidemia as a risk factor for Trousseau syndrome-related cerebral infarction in patients with advanced gastrointestinal cancer. Oncology letters. 2022. 24. 3. 318-318
- Hiroyuki Suzuki, Hideki Iwamoto, Ken Yamamoto, Mai Tsukaguchi, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Takashi Niizeki, Shusuke Okamura, et al. DNA Methylation in Noncancerous Liver Tissues as Biomarker for Multicentric Occurrence of Hepatitis C Virus-Related Hepatocellular Carcinoma. Gastro hep advances. 2022. 1. 4. 555-562
- Hiroyuki Suzuki, Hideki Iwamoto, Masahito Nakano, Toru Nakamura, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Dan Nakano, Ryoko Kuromatsu, Takashi Niizeki, et al. Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments. Translational oncology. 2021. 14. 11. 101201-101201
- Masuda A, Nakamura T, Abe M, Iwamoto H, Sakaue T, Tanaka T, Suzuki H, Koga H, Torimura T. Promotion of liver regeneration and anti?fibrotic effects of the TGF?β receptor kinase inhibitor galunisertib in CCl4?treated mice. Int J Mol Med. 2020. 46. 1. 427-438
- Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Takashi Niizeki, Masahito Nakano, Tomotake Shirono, Shusuke Okamura, Yu Noda, Naoki Kamachi, Toru Nakamura, et al. Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability toward Adverse Events. Cancers. 2020. 12. 4
- Sakaue T, Koga H, Iwamoto H, Nakamura T, Ikezono Y, Abe M, Wada F, Masuda A, Tanaka T, Fukahori M, Ushijima T, Mihara Y, Naitou Y, Okabe Y, Kakuma T, Ohta K, Nakamura K, Torimura T. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer. Med Mol Morphol. 2019. 52. 4. 198-208
- Fumitaka Wada, Hironori Koga, Jun Akiba, Takashi Niizeki, Hideki Iwamoto, Yu Ikezono, Toru Nakamura, Mitsuhiko Abe, Atsutaka Masuda, Takahiko Sakaue, et al. High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine. Cancer science. 2018. 109. 9. 2801-2810
- Teruko Arinaga-Hino, Tatsuya Ide, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Toru Nakamura, Takumi Kawaguchi, Hironori Koga, et al. Risk of malignancies in autoimmune hepatitis type 1 patients with a long-term follow-up in Japan. Hepatology research : the official journal of the Japan Society of Hepatology. 2018. 48. 3. E222-E231
- Mitsuhiko Abe, Takafumi Yoshida, Jun Akiba, Yu Ikezono, Fumitaka Wada, Atsutaka Masuda, Takahiko Sakaue, Toshimitsu Tanaka, Hideki Iwamoto, Toru Nakamura, et al. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury. World journal of gastroenterology. 2017. 23. 37. 6833-6844
- Yu Ikezono, Hironori Koga, Jun Akiba, Mitsuhiko Abe, Takafumi Yoshida, Fumitaka Wada, Toru Nakamura, Hideki Iwamoto, Atsutaka Masuda, Takahiko Sakaue, et al. Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1. Molecular cancer research : MCR. 2017. 15. 6. 744-752
前のページに戻る
